More than two million people in the UK are now using weight-loss medications, and the resulting shift in consumer spending is beginning to register at a national level, according to market research published by the BBC.
A study by Worldpanel by Numerator, based on survey responses and observed purchase data from more than 11,000 households in February 2026, found that households with at least one GLP-1 user spent on average £418 less on groceries in the year after starting medication, compared with non-users. This amounted to a fall of £780m in grocery spending nationally, the BBC reported.
Grocery Spending Falls by £780m
The research, which tracks spending before and after adoption of GLP-1 drugs such as Wegovy (Novo Nordisk) and Mounjaro (Eli Lilly), reveals a clear downward impact on food and drink expenditure. The findings are consistent with a peer-reviewed study from Cornell University, published last year, which found that US households with at least one member using weight-loss drugs spent 5% less on groceries within six months of starting the medication, with that rising to 8% among higher income families.
The following table summarises the key spending changes among UK GLP-1 user households:
| Metric | Value | Source |
|---|---|---|
| Average annual grocery saving per household | £418 | Worldpanel by Numerator (Feb 2026) |
| Total national grocery spending reduction | £780m | Worldpanel by Numerator (Feb 2026) |
| US grocery spend decrease (within 6 months) | 5% overall, 8% for higher income | Cornell University (peer-reviewed) |
| UK households with GLP-1 users (total) | >2 million | BBC estimate |
Shopper Basket Composition Shifts
Beyond the reduction in overall spending, the Worldpanel study uncovered notable changes in the types of products purchased. According to the BBC, users are buying less chocolate, pastries and alcohol, and more fresh fruit, protein-rich foods such as prawns, fresh juice and smoothies. The shift reflects a likely reduction in boredom-related eating and more intentional food choices.
Interestingly, the data also shows an increase in spending on chewing gum, mouthwash, and hair styling products and dyes — products that counter common GLP-1 side effects like thinning hair and bad breath.
Retailers and Manufacturers Adapt
The BBC noted that the trend is already influencing retailers and food manufacturers. Some are introducing smaller snack packs and developing healthier product formulations. Others are exploring dedicated shopping sections or advice for weight-loss medication users. The pharmaceutical industry is also closely watching the downstream effects, as changes in diet and spending could affect demand for other health-related products.
Case Studies Illustrate Behaviour Change
The BBC spoke to two UK users about their experience. Annie Haslam, 71, from Redruth, Cornwall, has taken weight-loss jabs for about 18 months and gone from 86kg to around 63.5kg. She buys less food and less instantly satisfying food like biscuits or puddings, eating a lot healthier and smaller portions. However, she has spent a considerable amount on clothes because her old clothes no longer fit.
Brad Channer, 42, from Newcastle, reported that he has saved money overall but spent around £70 on haircare products to address thinning hair — a common side effect. His case illustrates the niche market that has emerged for weight-loss-related grooming and apparel.
Next Milestone
Retailers and consumer goods companies will report their next quarterly earnings in the coming months, offering further insight into how spending patterns are evolving. Industry analysts are expected to scrutinise category-level data for signs of sustained change driven by GLP-1 adoption.
Sources:
